| | Title of Article | Author(s) |
| 1 | A Flexible Intravenous (IV) Catheter Should Be Used for a Chemotherapeutic IV Device to Prevent Drug Extravasation. | Hirofumi Mukai, N Katsumata, K Ishii, K Ozawa, K Tanoue,Yamamoto, T Watanabe |
| 2 | Amelioration of Adriamycin Skin Necrosis: An Experimental Study | Martin H. Cohen. |
| 3 | Assessing and Managing Venous Irritation Associated with Vinorelbine Tartrate (Navelbine®) | Cynthia N. Rittenberg, Richard J. Gralla, Teresa A. Rehmeyer. |
| 4 | Case Report: Topical DMSO for Mitomycin-C-Induced Skin Ulceration | David S. Alberts, Robert T. Dorr. |
| 5 | Central venous catheters-time for a change | Michael O’Leary, David Bihari |
| 6 | Complications of Intravenous Fluorescein Injections | Barry K. Lipson, Lawrence A. Yannuzzi. |
| 7 | Compounds and Methods that Reduce the Risk of Extravasation Injury Associated with the Use of Vesicant Antineoplastic Agents | Avner Ramu |
| 8 | Cutaneous Ulceration Due to Contrast Extravasation.Experimental Assessment of Injury and Potential Antidotes | Elam EA, Dorr RT, Lagel KE, Pond GD |
| 9 | Development of liposomal anthracyclines: from basics to clinical applications | Alberto Gabizon, Dorit Goren, Rivka Cohen, Yechezkel Barenholz |
| 10 | Diagnosis and Management of Spinal Epidural Space Extravasation Complicating Percutaneous Central Venous Line Placement in a Premature Infant: Case Report and Review of Literature | A. Vidwans, D. Neumann, N. Hussain, T. Rosenkrantz and M. Sanders, Univeristy of Connecticut School of Medicine, Farmington. |
| 11 | Dose-dependent skin ulcers in mice treated with DNA binding antitumor antibiotics | Michelle J. Soble, Robert T. Dorr, Patricia Plezia, and Steven Breckenridge. |
| 12 | Dosimetric Consequences of Radiopharmaceutical Infiltrations | Frank P. Castronovo, Jr. Kenneth A. McKusick, H. William Strauss |
| 13 | Efficacy of sodium thiosulfate as a local antidote to mechlorethamine skin toxicity in the mouse. | Robert T. Dorr, Michelle Soble, and David S. Alberts. |
| 14 | Evaluation and Treatment of Chemotherapy Extravasation Injuries | Elizabeth Kassner |
| 15 | Extravasation Injuries and Emergency Suction as Treatment | Vandeweyer E, Heymans O, Deraemaecker R. |
| 16 | Extravasation Injury Associated with Low-Dose Dopamine | Julie L Chen, Marianne O’Shea |
| 17 | Fibrin sheath formation and chemotherapy extravasation: a case report | Donna Jo Mayo |
| 18 | Frequency and Effects of Extravasation of Ionic and Nonionic CT Contrast Media during Rapid Bolus Injection | Michael P. Federie, Paul J. Chang, Scharmen Confer, Bertan Ozgun. |
| 19 | Hyaluronidase in the Prevention of Sclerotherapy-induced Extravasation Necrosis | Steven E Zimmet |
| 20 | Hyaluronidase For Treating Intravenous Extravasations | Barbara J. Few |
| 21 | Hyaluronidase Treatment for Intravenous Phenytoin Extravasation | Deborah K Sokol, Alan Dahlmann, David W. Dunn. |
| 22 | Hyaluronidase-injectable microparticles intended for the treatment of extravasation | T. Modena, B. Conti, I. Genta, F. Pauanetto, M. E. Tira, P. Sini, A. Gazzaniga |
| 23 | Ifosfamide Extravasation | Javier Mateu, Monica Alzamora, Mercedes Franco, Maria-Jose Buisan |
| 24 | IV Vesicants: How to Avoid Extravasation | Laura Wood and Shirley Gullo |
| 25 | Mediastinitis Related to Probable Central Vinblastine Extravasation in a Woman Undergoing Adjuvant Chemotherapy for Early Breast Cancer | C.M. Anderson, R.S. Walters and G.N. Hortobagyi |
| 26 | Mode of Chemotherapy Does not Affect Complications with an Implantable Venous Access Device | Danielle F. Brown, Pharm.D, Michael J. Muirhead, M.D., Patrick M. Travis, M.D.,Sharon R. Vire, Pharm.D., JoAnn Weller, R.N., Martin Hauer-Jensen, M.D., Ph.D. |
| 27 | Nafcillin Extravasation Injury – Use of Hyaluronidase as an Antidote | Karin E. Zenk, Claibourne I. Dungy, Gerald R Greene. |
| 28 | Peripheral venous cannulation: reducing the risks | JL Peters, BSc, FRCS, JD Frame, FRCS, and S M Dawson SRN, OHNC |
| 29 | Preventing the scars of neonatal intensive care | Jane Davies, David Gault, Roger Buchdahl. |
| 30 | Prevention and Management of Extravasation of Cytotoxic Drugs | Gianfilippo Bertelli |
| 31 | Prevention of Adriamycin-Induced Full-Thickness Skin Loss Using Hyaluronidase Infiltration | Joseph J. Disa, Raymond R. Chang, Samuel J. Mucci and Nelson H. Goldberg |
| 32 | Probe High Extravasation Rates | AM Jones, A Stanley |
| 33 | Reducing the risk of thrombophlebitis.Comparison of Teflon and Vialon cannulae | Trish Kerrison RGN, Jane Woodhull RGN |
| 34 | Severe Necrosis Due to Paclitaxel Extravasation | Jon D. Herrington, José A. Figueroa |
| 35 | Skin Ulceration Potential of Paclitaxel in a Mouse Skin Model In Vivo | Robert T. Dorr, Kristi Snead, James D. Liddil. |
| 36 | Soft-tissue Reconstruction Following Extravasation Of Chemotherapeutic Agents | Saleh M. Shenaq, MD, El-Hussaen A. Abbase, MD, and Jeffrey D. Friedman, MD |
| 37 | Surgical Management After Doxorubicin And Epirubicin Extravasation | C. Heitmann, C. Durmus, G. Ingianni |
| 38 | Surveillance of the Patient Receiving Infusional Cancer Chemotherapy: Nursing Role in Recognition and Management of Catheter-Related Complications | Cherie Moore, Donna Strong, June Childress, Barbara Fougere, and Susan Gotthardt. |
| 39 | Taxol extravasation: A case report | W.L. Bailey, R.M. Crump. |
| 40 | Taxol-Induced Cellulitis after Extravasation: A Rarely Reported Event | Moshe Efraim Stein, Kerem Drumea, Rasem Abu-Rasmi, Nissim Haim. |
| 41 | The Hyaluronan Receptor (CD44) Participates in the Uptake and Degradation of Hyaluronan | Martine Culty, Huong A. Nguyen, and Charles B. Underhill |
| 42 | The Prevention of Cutaneous Necrosis Following Extravasation of Hypertonic Saline and Sodium Tetradecyl Sulfate | Steven E. Zimmet |
| 43 | The Use of Hyaluronidase in the Treatment of Intravenous Extravasation Injuries | William V. Raszka, Thomas K. Kueser, Franklin R. Smith, James W. Bass. |
| 44 | Treatment Of Extravasation of Both Doxorubicin And Vincristine Administration In A Y-Site Infusion | Dolors Comas, Javier Mateu. |
| 45 | Treatment of Extravasation from Parenteral Nutrition Solution | Maria-Esperanza Gil, Javier Mateu. |
| 46 | Treatment of extravasation injury (Letter) | P.M. Murphy, D.T. Gault. |
| 47 | Vinorelbine Tartrate (Navelbine®): Drug Profile and Nursing Implications of a New Vinca Alkaloid | Janice M. Brogden and Brenda Nevidjon |
| 48 | Delayed adverse skin reactions associated with mitomycin-C administration.Oncol Nurs Forum 11(4):14-18, 1984. | Wood, H.A.; Ellerhorst-Ryan, J.M |
| 49 | Mitomycin-C-induced skin ulceration remote from infusion site. Cancer Treat Rep 65(5-6):529, 1981. | Johnston-Early, A.; Cohen, M. |
| 50 | Delayed tissue necrosis due to mitomycin C. Acta Derm Venereol 67(4):364-366, 1987. | Aizawa, H, Tagami, H. |
| 51 | Paclitaxel-induced “recall” soft tissue injury occurring at the site of previous extravasation with subsequent intravenous treatment in a different limb. J Clin Oncol 1994;12:2237-8. | Shapiro J, Richardson GE. |
| 52 | Case report of Taxol administration via central vein producing a recall reaction at a site of prior Taxol extravasation. J Natl Cancer Inst 1994;86:1250-1. | Meehan JL, Sporn JR. |
| 53 | Paclitaxel-induced “recall” soft tissue ulcerations occurring at the site of previous subcutaneous administration of paclitaxel in low doses. Gynecol Oncol 1996;60:94-6. | DuBois A, Kommoss FGM, Pfisterer J, Luck Hj, Meerpohl HG. |
| 54 | Daunomycin, adriamycin, and recall effect. Ann Intern Med 1976; 85: 259-60 | Baer D, Wilkinson S. |
| 55 | Recall injury from adriamycin [letter]. Ann Intern Med 1975; 83: 232 | Cohen C, Dibella NJ, Michalak JC. |
| 56 | Taxol and radiation-recall dermatitis [letter]. Lancet 1993: 341: 1354 | Raghavan V. Bloomer W, Merkel D. |
| 57 | Mitomycin C extravasation exacerbated by sunlight [letter). Ann Intern Med 1981; 94: 542 | Fuller B, Lind M, Bonomi P. |
| 58 | Adriamycin activating a recall phenomenon after radiation therapy. Ann Intern Med 81:407,1474 | Donaldson SS, Glick JM, Wilbur JR: |
| 59 | Therapy of local toxicities caused by extravasation of cancer chemotherapeutic drugs. Cancer Treatment Reviews, 7, 17-27.1980 | IGNOFFO, R. J., and FRIEDMAN, M. A., |
| 60 | Extravasation: a hazard of intravenous therapy. Drug Intell Clin Pharm 1983:17:713-717 | MacCara ME |
| 61 | Extravasation of Drugs. In Kaufman L, Ginsburg R,(Eds) Anaesthesia Review 13, Churchill Livingstone, Edinburgh 1997 | Gault D, Challands J |
| 62 | Skin necrosis from extravasation of intravenous fluids in children. Plast Reconstr Surg 1979;64(2):145-150 | Brown AS, Hoelzer DJ, Piercy SA |
| 63 | Major intravenous extravasation injuries. Am J Surgery 1979;137:497-506 | Upton J, Mulliken JB, Murray JE |
| 64 | Prevention and treatment of extravasation. Br J Parenteral Therapy 1985;6:114-120 | Smith R |
| 65 | Complications of intravenous therapy with steel needles and Teflon catheters: a comparative study. Am J Med 1981;70:702-706 | Tully JL, Friedland GH, Baldini LM, Goldman DA. |
| 66 | Use of liposuction and saline washout for the treatment of extensive subcutaneous extravasation of corrosive drugs. Br J Anaes 1994;72:702-704. | Martin PH, Carver N, Petros AJ |
| 67 | Extravasation Injury to the hand by intravenous phenytoin . J Neurosurg 1988;68(6):967-969 | Rao VK, Feldman PD, Dibbell DG |
| 68 | Acute management of dopamine infiltration injury with Regitene. Plast Reconstr Surg 1987;80(4):610-612 | Siwy BK, Sadove AM |
| 69 | Persistence of anthracycline levels following dermal and subcutaneous Adriamycin extravasation. Proc Am Assoc Cancer Res 1981;4:96 | Garnick M, Israel M, Khetarpal V et al. |
| 70 | Histologic changes induced in skin by extravasations of doxorubicin (adriamycin). J Cutan Pathol 1989;16:158-163 | Bhawan J, Petry J, Rybak ME |
| 71 | Management of intravenous extravasations. Infusion 1981;5(4):77-79 | Zenk KE. |
| 72 | Extravasations of Oxaliplatin (Correspondence) | Albrecht Kretzschmar, Daniel Pink, Peter Thuss-Patience, Bernd Dörken, Peter Reichart, Robert Eckert |
| 73 | The management of paclitaxel (Taxol®) extravasation | A. Stanley, S. Marsh |
| 74 | Extravasation of topotecan, a report of two cases | Lonneke MM Oostweegel, MD, Laurence JC van Warmerdam, PhD, Margaret Schot, Ria C Dubbelman, Wim W Ten Bokkel Huinink, MD, Jos H Beijnen, PhD |
| 75 | Risk factors affecting infiltration of peripheral venous lines in infants. J Paediatrics 1987;111:384-389 | Phelps SJ, Helms RA |
| 76 | Pitfalls in anaesthetic practice. Br J Anaesthesia 1987;59:877-890 | Utting JE |
| 77 | Therapeutic effect and toxicity of Adriamycin in patients with neoplastic disease. Cancer 1971;28:837-843 | Wang JJ, Cortes E,Sinks LF, Holland JF |
| 78 | Extravasation of epirubicin/vincristine and ifosfamide/mesna from a central venous catheter | Penelope Jane Webster, BPharm, Dip Hosp Pharm
Deirdre D’Souza, BPharm |
| 79 | Docetaxel-induced extravasation injury: a report of three cases | Bruce R Harrison, MS, RPh, BC0P, Jennifer R Ketts, PharmD Michelle Z Schultz, MD and Susan Yackzan, MSN, RN, AOCN |
| 80 | Knowledge is power when treating extravasation reactions | Lisa McDonald, PharmD |
| 81 | Reducing the Morbidity From Extravasation Injuries(external link) | Khan, Mansoor S. BSc (Hons), MBChB, MRCS, AFRCS; Holmes, J. D. MChir, FRCS(Plast) |
| 82 | Utilization of dimethyl sulfoxide for treating anthracycline extravasation | Raylene M. Rospond, PharmD, BCPS |
| 83 | A New Conservative Approach to Extravasation of Anthracyclines with Dimethylsulfoxide and Dexrazoxane | Annelies M. E. Bos, Winette T. A. van der Graaf and Pax H. B. Willemse |
| 84 | Contrast media extravasation in upper abdominal injuries: detection with spiral computerized tomography | Catalano O, Lobianco R, Esposito M, Sandomenico F, Siani A. |
| 85 | Extravasation Detection Accessory: Clinical Evaluation in 500 Patients | Bernard A. Birnbaum, MD, Rendon C. Nelson, MD, Judith L. Chezmar, MD and Seth N. Glick, MD |
| 86 | Unsound Practice:the epidemiology of medical negligence. Medical Law Review 1995;3:53-73 | Hoyte P |
| 87 | Clinical Governance:Making it Happen. RSM Press, London 1999 | Lugon M, Secker-Walker J |
| 88 | Antidotes to Vesicant Chemotherapy Extravasations | Dorr RT |
| 89 | Pitfalls in Anaesthetic Practice. Br J Anaesthesia 1987;59:877-890 | Utting JE |
| 90 | Intravenous Infusion in Neonates. J Med Defence Union 1986;2:4 | Sanderson I |
| 91 | England and Wales introduce new system for medical negligence claims | Dyer C |
| 92 | Current thoughts on extravasation injuries. Clinics in Plastic Surgery 1989;16(3):557-563. | Heckler FR |
| 93 | Glyceryl trinitrate in skin necrosis caused by extravasation of parenteral nutrition. Lancet. 1988 Sep 3;2(8610):565-6. | O’Reilly C, McKay FM, Duffty P, Lloyd DJ. |
| 94 | A prospective study of topical DMSO for treating anthracycline extravasation. J Clin Oncol 1988;6(11);1732-1735. | Olver IN, Aisner J, Hament A et al |
| 95 | What is the appropriate management of tissue extravasation by antitumor agents? Plastic and Reconstructive Surgery 1985; 75: 397-405. | LARSON DL |
| 96 | Treatment of tissue extravasation by antitumor agents. Cancer 1982 ;49: 1796-9. | LARSON DL |
| 97 | Statistics from the National Extravasation Information Service green card reporting database 1987-2005 | Hawley I |
| 98 | Extravasation of calcium gluconate concomitant with osteomyelitis in a neonate. | Chiang MC, Chou YH, Wang CR, Huang CC. |